We studied the expression of PD-1 on CD4 T cells and found that there was an increase in all non-naïve CD4 T cells from patients, which was statistically significant in the effector-memory subset from moderate and severe COVID-19 patients (Figure 2C and Supplementary Figure 3B). The gene discussed is CD4; the disease is COVID-19.